Close mobile menu×
Close mobile menu

Rajani Sharma, MD, MSc

Board Certifications: 
Internal Medicine
Expertise in: 
Hepatology, Gastroenterology
Accepting New Patients
Profile Headshot

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Internal Medicine

Clinical Expertise

  • Cirrhosis
  • Complication of Liver Disease
  • Hepatocellular Carcinoma
  • Liver Disease
  • Liver Transplant
  • Liver Transplant Evaluation
  • Portal Hypertension

Honors & Awards

  • 2019 Transplant Forum Travel Scholar Award
  • 2019 American Society of Transplantation, Liver and Intestinal Community of Practice Travel Grant for Best Trainee Research Project, American Transplant Congress Conference
  • 2019 Best Trainee Research Award, Young Investigators Forum, Controversies in Liver Transplantation Annual Conference
  • 2017 NIH T32 Training Grant Fund Recipient, Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, PI: Dr. Timothy Wang, MD
  • 2017 Tuition Scholarship for MS in Patient Oriented Research, Columbia University Mailman School of Public Health
  • 2016 Senior Resident Teaching Award, Columbia University Irving Medical Center, Department of Medicine
  • 2013 Highest Academic Achievement Award, Robert Wood Johnson Medical School
  • 2013 Diane Barton, MD Endowed Scholarship, Robert Wood Johnson Medical School and the NJ Health Fund

About Rajani Sharma

Dr. Rajani Sharma earned her AB at Princeton University prior to attending Rutgers University-Robert Wood Johnson Medical School. She completed her residency in Internal Medicine at New York Presbyterian Hospital-Columbia University Irving Medical Center, where she received a resident teaching award. She then completed her gastroenterology fellowship and transplant hepatology fellowship also at New York Presbyterian Hospital-Columbia University Irving Medical Center. During her gastroenterology fellowship, she earned a Masters in Patient Oriented Research at the Mailman School of Public Health.

Dr. Sharma strives to provide empathetic and thoughtful care that focuses on the specific needs of each of her patients. Her clinical practice is focused on the management of all types of liver disease. In addition, Dr. Sharma has specialized training in managing complications of end-stage liver disease and caring for patients before and after liver transplantation.

Academic Titles

  • Assistant Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Weill Cornell Medical Center
  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Female

Contact & Locations

622 West 168th Street
PH, Floor 14
New York, New York 10032


Research Interests

  • Autoimmune hepatitis
  • Clinical outcomes of chronic liver disease and post liver transplant patients

Selected Publications

  1. Sharma R, Axelrad JA, Laszkowska M, Packey C, Rosenberg R, Lebwohl B. Increased healthcare utilization by Medicaid patients with inflammatory bowel disease at a tertiary care?center. IBD Journal. Epub April 2019.
  2. Laurito MP, Silva GF, Cheinquer H, Sharma R, Verna EC, Parise ER. Does insulin resistance impair the virologic response to peginterferon/ribavirin in chronic hepatitis C genotype 3 patients? Arquivos de Gastroenterologia. June 2018; 55 (2): 179-183.
  3. Sharma R, Brown RS. Treatment of hepatitis C virus in advanced renal disease. Clinical Liver Disease. September 2017; 10(3): 79-81.
  4. Sharma R, Roy A, Ramos C, Rosenberg R, Garcia-Carrasquillo R, Lebwohl B. Low adherence to national guidelines for proton pump inhibitor prescription in patients receiving combination aspirin and anticoagulation. Therapeutic Advances in Gastroenterology. 2017, May; 10(5): 387-396.
  5. Sharma R, Prudente S, Andreozzi F, Powers C, Mannino G, Bacci S, Gervino EV, Hauser TH, Succurro E, Mercuri L, Goheen EH, Shah H, Trischitta V, Sesti G, Doria A. The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects. Atherosclerosis. 2011, May; 216(1): 157-160.